How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers

Compulsory licensing might be the answer  

Nigeria at sixes and sevens on COVID-19 vaccine rollout

Nigeria plans to vaccinate 40% of its citizens before end of 2021 and 70% by end of 2022

Lateral Thoughts: A paradigm change in clinical trials

The rich and famous are clamouring to get the ‘experimental’ COVID-19 vaccine

Simply put: COVID-19 vaccine exploration

Lateral Thoughts: Healthy ageing was never so attractive

Accessing COVID-19 vaccine is logistically difficult for the old and sick  

South African case study sheds light on how vaccine manufacturing can be developed

Additional costs made it harder for local companies to break even and recover working capital

Interested in vaccine rollouts across Africa? Here’s a map to guide you

A map that will be updated daily, showing how many people have been vaccinated across the continent

जग बीती: खुशियों का इंडेक्स

COVID-19 vaccine: 74% scheduled health workers didn't get second shot

Less than half the scheduled workers have received the first shot

देश भर में शुरू हुआ कोविड-19 वैक्सीन लगाने का काम

उत्तर प्रदेश, मध्य प्रदेश, राजस्थान, उत्तराखंड, हिमाचल प्रदेश में वैक्सीन की शुरुआत सामान्य रही

कोरोना वैक्सीन के बाद नॉर्वे में 23 लोगों की मौत, सरकार ने दिया स्पष्टीकरण

नॉर्वे की मेडिसिन एजेंसी ने कहा कि मरने वाले बुजुर्ग थे और कई गंभीर बीमारियों से ग्रस्त थे

कोरोना वैक्सीन अपडेट: सरकार ने कहा, स्वैच्छिक होगा वैक्सीन की डोज लेना

कोरोनावायरस वैक्सीन को लेकर अब तक क्या कुछ हो रहा है, पढ़ें आज का अपडेट-

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Important questions remain: It’s unclear how long protection will last and if the vaccine protects against severe disease

What we know so far about COVID-19 vaccine: A comprehensive guide by academic experts

With so much at stake, it’s not surprising that COVID-19 vaccines have become a public and political obsession. The good news is that …

Tika Utsav and Vaccine Maitri: Finding the right balance

67% medicines produced in India are exported to developing countries

Scientific innovation in 2021: Lessons from COVID-19

One of the bigger learnings of 2020 was that it takes time, planning, trust and bringing together of resources as well as knowledge to manage a …

Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa

Oxford COVID vaccine authorised in the UK – global health expert on why this is a key moment

To know the impact of the Oxford vaccine, we’ll have to wait and see. However, amid the intense doom and gloom of 2020, having multiple …

Roti, kapda, makaan... and vaccine: Can it sway elections

With potential COVID-19 vaccines equalling cheap foodgrains’ power as a poll promise, can vaccine sub-nationalism be far behind

Simply put: Let’s plant a COVID-19 vaccine

Simply Put: The vaccine

DCGI clears Bharat Biotech, SII COVID-19 vaccines but efficacy question unanswered

CDSCO official says BB vaccine to be used in public but to exclude people with COVID-19, other infections

New COVID-19 variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’

At least 3 documented SARS-CoV-2 variants of concern can reinfect recovered patients and vaccinated individuals 

Resurgence of COVID-19 cases serious concern: Centre

‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …

कोरोना वैक्‍सीन लगने के अगले द‍िन स्वास्थ्य कर्मी की मौत

परिवार का आरोप है कि वैक्‍सीन लगने के बाद तबियत खराब हुई जबकि पोस्‍टमॉर्टम रिपोर्ट में मौत का कारण हार्ट अटैक बताया गया है